Patents by Inventor Kalyanam Nagabhushanam

Kalyanam Nagabhushanam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10085963
    Abstract: Disclosed is a method of achieving optimal mammalian energy balance using forskolin on a particular physiological and developmental stage of the mammalian cellular system.
    Type: Grant
    Filed: November 10, 2015
    Date of Patent: October 2, 2018
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sarang Bani, Anjali Pandey
  • Patent number: 10071043
    Abstract: Disclosed is the a method of effecting skin hydration and enhancing skin barrier function, said method comprising the step of bringing into contact a pentapeptide conjugate of oleanolic acid with skin cells so that the effect of increased cellular communication at the molecular level to bring about gene and protein expression in the cells of the skin that enable hydration and skin barrier functions are realized.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: September 11, 2018
    Assignee: SAMI LABS LIMITED
    Inventors: Kalyanam Nagabhushanam, Muhammed Majeed
  • Publication number: 20180168182
    Abstract: Disclosed is a method for the preparation of a gummy and candy composition containing curcuminoids. Also disclosed is a gummy and candy composition containing effective concentration of curcuminoids that is palatable and bioavailable.
    Type: Application
    Filed: December 19, 2017
    Publication date: June 21, 2018
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Anurag Pande, Shaheen Majeed
  • Publication number: 20180117127
    Abstract: The present invention discloses a combination of digestive enzymes (Protease, Amylase, Lactase, Lipase, Cellulase)—DigeZyme® for the therapeutic management of delayed onset muscle soreness (DOMS)
    Type: Application
    Filed: November 3, 2016
    Publication date: May 3, 2018
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Shaheen Majeed
  • Patent number: 9913809
    Abstract: The present invention provides a method of using (E)-1-(3?, 4?-dimethoxyphenyl) butadiene to induce anti-tumorigenic effects in pancreatic carcinoma, ovarian carcinoma, prostate carcinoma, colon carcinoma, lung carcinoma, lymphoblastoma, melanoma and colorectal carcinoma. The invention also provides a method of using (E)-1-(3?, 4?-dimethoxyphenyl) butadiene to prevent cancer metastasis.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: March 13, 2018
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam
  • Publication number: 20180064658
    Abstract: The present invention provides a method of using (E)-1-(3?,4?-dimethoxyphenyl) butadiene to induce anti-tumorigenic effects in pancreatic carcinoma, ovarian carcinoma, prostate carcinoma, colon carcinoma, lung carcinoma, lymphoblastoma, melanoma and colorectal carcinoma. The invention also provides a method of using (E)-1-(3?,4?-dimethoxyphenyl) butadiene to prevent cancer metastasis.
    Type: Application
    Filed: November 1, 2017
    Publication date: March 8, 2018
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam
  • Publication number: 20180000873
    Abstract: The present invention discloses the use of probiotics for therapeutic management of major depressive disorder (MDD). Specifically, the invention discloses the method of therapeutically managing MDD in mammals with Irritable bowel syndrome using probiotic strain Bacillus coagulans MTCC 5856.
    Type: Application
    Filed: June 30, 2016
    Publication date: January 4, 2018
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Furqan Ali
  • Patent number: 9833422
    Abstract: The present invention provides a method of using (E)-1-(3?, 4?-dimethoxyphenyl) butadiene to induce anti-tumorigenic effects in pancreatic carcinoma, ovarian carcinoma and prostate carcinoma. The invention also provides a method of using (E)-1-(3?, 4?-dimethoxyphenyl) butadiene to prevent cancer metastasis.
    Type: Grant
    Filed: November 24, 2016
    Date of Patent: December 5, 2017
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam
  • Publication number: 20170332685
    Abstract: The present invention discloses a functional nutritional blend comprising Gynostemma pentaphyllum extract, Coleus forskohlii extract, Zingiber officinale extract and piperine, for increasing metabolic efficiency and inhibition of adipogenesis.
    Type: Application
    Filed: May 19, 2017
    Publication date: November 23, 2017
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Mitchell Chavez
  • Publication number: 20170327785
    Abstract: Disclosed herein is a composition containing turmeric starch for use as a prebiotic plant fiber. Also disclosed is a method to increase the viable counts of Bacillus coagulans MTCC 5856 by co-culturing with turmeric starch and the production of short chain fatty acids (SCFA) by Bacillus coagulans MTCC 5856 using turmeric starch.
    Type: Application
    Filed: July 27, 2017
    Publication date: November 16, 2017
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Furqan Ali
  • Patent number: 9782450
    Abstract: Disclosed are methods of managing obesity and hypercholesterolemia using a composition of matter comprising the ethyl acetate fraction of the extract of Cyperus rotundus rhizomes standardized to contain 5% of total stilbenes.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: October 10, 2017
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Douglas Kalman, Beena Bhat, Priti Vaidyanathan, Sarang Bani, Anjali Pandey, Suresh Karri
  • Publication number: 20170274023
    Abstract: Disclosed herein is (i) a method related to the growth promotional activity of plant based fibres on Bacillus coagulans MTCC 5856; (ii) the combination of plant based fibres and Bacillus coagulans MTCC 5856 to inhibit Gram Negative pathogenic bacteria; and (iii) the production of short chain fatty acids (SCFA) by Bacillus coagulans MTCC 5856 using plant based fibres.
    Type: Application
    Filed: June 14, 2017
    Publication date: September 28, 2017
    Applicant: SAMI LABS LIMITED
    Inventors: Muhammed MAJEED, Kalyanam NAGABHUSHANAM, Sivakumar ARUMUGAM, Furqan ALI
  • Publication number: 20170239311
    Abstract: Disclosed is the adaptogenic activity of boswellic acids-polysaccharide compositions derived from Boswellia serrata in combination with either (i) the concentrate of the liquid endosperm of Cocos nucifera or (ii) the extract of Emblica officinalis fruit standardized to contain 10% w/w and above of 1-O-galloyl-?-D-glucose (?-glucogallin).
    Type: Application
    Filed: February 24, 2016
    Publication date: August 24, 2017
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam
  • Patent number: 9737502
    Abstract: The present invention discloses the potential of Calebin A in attenuating high fat diet (HFD) induced hepatic steatosis in mammals.
    Type: Grant
    Filed: April 19, 2015
    Date of Patent: August 22, 2017
    Assignee: SAMI LABS LIMITED
    Inventors: Kalyanam Nagabhushanam, Anju Majeed, Muhammed Majeed
  • Patent number: 9717766
    Abstract: The present invention disclosed herein describes (i) the growth promotional activity of natural plant based fibres on Bacillus coagulans MTCC 5856; (ii) the combination of natural plant based fibres and Bacillus coagulans MTCC 5856 to inhibit Gram Negative pathogenic bacteria and (iii) the production of short chain fatty acids (SCFA) by Bacillus coagulans MTCC 5856 using plant based natural fibres.
    Type: Grant
    Filed: August 29, 2015
    Date of Patent: August 1, 2017
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Furqan Ali
  • Publication number: 20170196820
    Abstract: The present invention provides a method of using (E)-1-(3?, 4?-dimethoxyphenyl) butadiene to induce anti-tumorigenic effects in pancreatic carcinoma, ovarian carcinoma and prostate carcinoma. The invention also provides a method of using (E)-1-(3?, 4?-dimethoxyphenyl) butadiene to prevent cancer metastasis.
    Type: Application
    Filed: November 24, 2016
    Publication date: July 13, 2017
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam
  • Patent number: 9681666
    Abstract: The antimicrobial effect of extracellular metabolite composition from Bacillus coagulans MTCC 5856 and composition comprising from about 61% w/w of thymol, about 38% of monolaurin and about 1% w/w of magnolol obtained from supercritical fluid extracts of Magnolia officinalis is described.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: June 20, 2017
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Furqan Ali
  • Patent number: 9681665
    Abstract: The antimicrobial effect of extracellular metabolite composition from Bacillus coagulans MTCC 5856 is described.
    Type: Grant
    Filed: July 20, 2016
    Date of Patent: June 20, 2017
    Assignee: SAMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Sivakumar Arumugam, Furqan Ali
  • Patent number: 9668999
    Abstract: Disclosed is a therapeutic management method of hypercholesterolemia in mammals. More specifically, the present invention relates to a method of reducing high levels of circulating cholesterol (hypercholesterolemia) in the blood stream of mammals, said method involving step of administering therapeutically effective amounts of Calebin A to said mammals to bring about the effects of (i) reducing the amount of total blood cholesterol levels; (ii) reducing the concentrations of low density lipoproteins (LDL) and very low density lipoproteins (VLDL); (iii) increasing the concentrations of high density lipoproteins (HDL) and (iv) reducing concentrations of serum triglycerides.
    Type: Grant
    Filed: April 23, 2014
    Date of Patent: June 6, 2017
    Assignee: SEMI LABS LIMITED
    Inventors: Muhammed Majeed, Kalyanam Nagabhushanam, Anju Majeed, Sarang Bani, Anjali Pandey
  • Publication number: 20170128410
    Abstract: Disclosed is a method of achieving optimal mammalian energy balance using forskolin on a particular physiological and developmental stage of the mammalian cellular system.
    Type: Application
    Filed: November 10, 2015
    Publication date: May 11, 2017
    Inventors: MUHAMMED MAJEED, Kalyanam Nagabhushanam, Sarang Bani, Anjali Pandey